布利纳图莫马布桥梁疗法用于缓解急性淋巴细胞白血病儿童的化学毒性
Ayça Koca Yozgat1, Özlem Arman Bilir1, İkbal Ok Bozkaya1
1Department of Pediatric Hematology and Oncology, Health Sciences University, Ankara City Hospital, Altındağ, Turkey.
概括
双特异性T细胞参与者Blinatumomab为患有急性淋巴细胞白血病 (ALL) 的儿科患者提供了一种非髓毒性选择,这些患者经历了化疗毒性. 这种方法可以继续治疗,并将其连接到进一步的化疗.
科学领域:
- 儿科瘤学 儿科瘤学
- 免疫治疗是一种免疫疗法.
- 血液学恶性瘤是什么
背景情况:
- 急性淋巴细胞白血病 (ALL) 是主要的儿童癌症.
- 高风险ALL患者面临与治疗相关的显著毒性.
- 布利纳莫马布已被批准用于复发性/耐药ALL,并具有明显的毒性概况.
研究的目的:
- 评估blinatumomab在儿科ALL患者的使用,这些患者有化疗诱导的毒性.
- 评估blinatumomab在允许继续ALL治疗中的有效性.
主要方法:
- 病例报告两名儿科患者在B前ALL.
- 由于与化疗相关的严重毒性,患者接受了blinatumomab.
- 治疗旨在将患者连接到随后的化疗.
主要成果:
- 两名患者在布利纳图马布治疗后从化疗毒性中恢复过来.
- 布利纳莫马布有助于成功过渡到进一步的化疗.
- 没有观察到显著的骨髓毒性.
结论:
- 布利纳莫马布可以成为患有化疗毒性的儿科ALL患者的可行选择.
- 这种免疫疗法可能有助于克服因毒性引起的治疗延迟.
- 需要对布利纳图马布的化学疗法诱导毒性进行进一步调查.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Bone Marrow Sampling and Transplants
276
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
276
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
